Identifying Risk Factors for Poor Glycemic Control Among Emergency Department Patients and Improving Linkage to Outpatient Care

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This goal of this NIH funded R01 study is to identify risk factors for not being able to follow-up for a new diagnosis of diabetes in the emergency department and improve linkage of these newly diagnosed patients to appropriate outpatient care. Its three aims will be accomplished through 1) a retrospective chart review of emergency department (ED) patients screened for diabetes, 2) a series of prospective qualitative interviews among ED patients with newly diagnosed diabetes who fail to follow-up for outpatient care, and 3) a simple randomized controlled trial to test the efficacy of telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 70
Healthy Volunteers: f
View:

• Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%

• Residential address in New York City or Long Island

• Primary language is English or Spanish

• Able to provide informed consent

Locations
United States
New York
NYU Langone Health
RECRUITING
New York
Contact Information
Primary
David C. Lee
David.Lee@nyulangone.org
212-562-6561
Time Frame
Start Date: 2025-09-15
Estimated Completion Date: 2028-05-31
Participants
Target number of participants: 200
Treatments
Experimental: Telehealth Bridge Visits
Patients in the experimental arm will receive post-emergency department telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.
Active_comparator: Control
Patients in the control arm will receive standard of care.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: NYU Langone Health

This content was sourced from clinicaltrials.gov